Back
to sessions
Sep 29
Plenary
PL 01 - Plenary
MODERATOR(S)
Kenneth Rosenzweig, MD, FASTRO - Icahn School of Medicine at Mount Sinai
Farzan Siddiqui, MD, PhD, FASTRO - Henry Ford Hospital/Wayne State University
session DESCRIPTION
The Plenary Session features broad, high-level presentations from leading experts on topics shaping the future of radiation oncology.
Credits
| AMA PRA Category 1 Credits: | 1.50 |
| CAMPEP Credits: | 1.50 |
| MDCB Credits: | 1.50 |
Presentations
-
01:30pm - 01:40pm PT
Phase III Randomized Trial of Proton vs. Photon Therapy for Patients with Non-Metastatic Breast Cancer Receiving Comprehensive Nodal Radiation: A Radiotherapy Comparative Effectiveness (RadComp) Consortium Trial: Health-Related Quality Of Life Outcomes
Speaker: Shannon MacDonald, MD, FASTRO - Southwest Florida Proton Center, Estero -
01:40pm - 01:48pm PT
Discussant
Speaker: Simona Shaitelman, MD, EdM - MD Anderson Cancer Center, Houston -
01:48pm - 01:58pm PT
Primary Results for the Phase III Trial of Toxicity Reduction using Proton Beam Therapy for Oropharyngeal Cancer (TORPEdO; CRUK/18/010)
Speaker: David Thomson, MD - The Christie NHS Foundation Trust, Manchester -
01:58pm - 02:06pm PT
Discussant
Speaker: Vinita Takiar, MD, PhD - University of Cincinnati College of Medicine, Cincinnati -
02:06pm - 02:16pm PT
Primary Results from NRG-GU005: A Phase III Trial of SBRT vs. Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Speaker: Rodney Ellis, MD - University South Florida and Tampa General Hospital Cancer Institute, Tampa -
02:16pm - 02:24pm PT
Discussant
Speaker: Matthew Abramowitz, MD - University of Miami, Miami -
02:24pm - 02:34pm PT
Bladder Adjuvant Radiotherapy (BART): Clinical Outcomes from a Phase III Multicenter Randomized Controlled Trial
Speaker: Vedang Murthy, MD - Tata Memorial Centre, New Mumbai -
02:34pm - 02:42pm PT
Discussant
Speaker: Brian Baumann, MD - Springfield Clinic, Springfield -
02:42pm - 02:52pm PT
Tumor Treating Fields (TTFields) After Stereotactic Radiosurgery (SRS) for Brain Metastases from Non-Small Cell Lung Cancer (NSCLC BM): Final Results of The Phase 3 METIS Trial
Speaker: Vinai Gondi, MD - Northwestern Medicine Warrenville Cancer Center and Proton Center, Warrenville -
02:52pm - 03:00pm PT
Discussant
Speaker: Helen Shih, MD, MS, FASTRO, MPH, AM - Massachusetts General Hospital, Boston